21st Century Oncology, one of the largest cancer treatment center operators in the country, has launched an initial public offering.
The Fort Myers, Fla.-based company plans to offer 13.3 million shares of common stock at $14 to $16 per share. 21st Century Oncology will also offer 1.5 million shares of preferred stock at $50 per share. Morgan Stanley, J.P. Morgan and Wells Fargo are the book-running managers for the IPO.
21st Century Oncology operates 185 treatment centers, specializing in radiation oncology and other medical specialty services. Daniel Dosoretz, MD, a radiation oncologist, co-founded the company and serves as its CEO.
More Articles on Healthcare and IPOs:
10 Things To Know About Castlight Health's IPO
IMS Health's $1.3B IPO Shows Investors Recognize Value of Big Data
Imprivata Files $115M IPO